The roles of E2A and Id2 in class switch recombination
The roles of E2A and Id2 in class switch recombination
批准号:
14570104
负责人:
SUGAI Manabu
金额:
$1.86万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
点击翻译按钮获取中文摘要
英文摘要
1.Immunoglobulin E (IgE) plays a central,role in the pathogenesis of allergic disorders but its serum level is kept much lower than other immunoglobulin classes in normal. In B cells lacking Id2, the highly augmented activity of E2A enhances ε germline transcription, and thus class switch recombination (CSR) to IgE. In wild-type B cells, in contrast, Id2 is induced by TGF-β1 and suppresses IgE CSR. This suppression does not occur in Id2 deficient B cells. Our results provide evidence for the inhibitory and selective role of Id2 in IgE CSR, especially in response to TGF-β1. indicating Id2 is a safeguard molecule.2.Pax5 activity is enhanced in activated B cells and is essential for class switch recombination (CSR). We show that Id2 suppresses CSR by repressing the gene expression of activation-induced cytidine deaminase (AID), which has been shown to be indispensable for CSR. Furthermore, a putative regulatory region of AID contains E2A-and Pax5-binding sites and the latter site is indispensable for AID gene expression. Moreover, the DNA binding activity of Pax5 is decreased in Id2-overexpressing B cells, and enhanced in Id2^<-/-> B cells. The kinetics of Pax5-occupancy, but not E2A, to AID locus is the same as AID expression in primary B cells. Finally, enforced-expression of Pax5 induces AID transcription in pro-B cell lines. Our results provide evidence that the balance between E2A, Pax5 and Id2 activities has a key role in AID gene expression.Thus, Id2 acts as a negative regulator to prevent potentially harmful effects brought about by excessive immunological reactions: one of its special roles is to maintain low serum concentrations of immunoglobulin E (IgE).
期刊论文(42)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Katakai, T., Hara, T., Sugai, M., Gonda, H., Shimizu, A.: "Th1-biased tertiary lymphoid tissue supported by CXCL13-producing stromal network in the chronic lesions of autoimmune gastritis"J.Immunol.. 171. 4359-4368 (2003)
Katakai,T.,Hara,T.,Sugai,M.,Gonda,H.,Shimizu,A.:“自身免疫性胃炎慢性病变中由产生 CXCL13 的基质网络支持的 Th1 偏向三级淋巴组织”J.Immunol
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Sugai M., Gonda H., Kusunoki T., Katakai T., Yokota Y., Shimizu A.: "Essential role of Id2 in negative regulation of IgE class switching."Nature Immunol. 4.(1). 25-30 (2003)
Sugai M.、Gonda H.、Kusunoki T.、Katakai T.、Yokota Y.、Shimizu A.:“Id2 在 IgE 类别转换负调节中的重要作用。”《自然免疫》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
楠 隆: "Th2 dominance and defective development of CD8+ dendritic cell subset in Id2-deficient mice"J Allergy Chin. Immunol.. 111・1. 136-142 (2003)
Takashi Kusunoki:“Id2缺陷小鼠中Th2优势和CD8+树突状细胞亚群的发育缺陷”J Allergy Chin. 111・1(2003)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Katakai, T., Hara, T., Sugai, M., Gonda, H., Shimizu, A.: "Th1 -biased tertiary lymphoid tissue supported by CXCL13-producing stromal network in the chronic lesions of autoimmune gastritis."J.Imnnunol.. 171. 4359-4368 (2003)
Katakai,T.,Hara,T.,Sugai,M.,Gonda,H.,Shimizu,A.:“自身免疫性胃炎慢性病变中由产生 CXCL13 的基质网络支持的 Th1 偏向三级淋巴组织。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 14 条
Development of new therapies for tumor and autoimmunity using CD8aaT cells
-
批准号:24659148
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.5万
-
财政年份:2012
-
负责人:SUGAI Manabu
-
依托单位:
Analysis of the functional difference among various Id proteins
-
批准号:21590307
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2009
-
负责人:SUGAI Manabu
-
依托单位:
Molecular analysis of ANKH toward gene therapy for TMD
-
批准号:17592073
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2005
-
负责人:SUGAI Manabu
-
依托单位:
Regulation of the Class Switch Recombination
-
批准号:16590226
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2004
-
负责人:SUGAI Manabu
-
依托单位:
国内基金
海外基金
登录
查看更多内容
染色体易位中E2A易碎区间AID脱氨和DNA断裂的分子机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:刘迪
-
依托单位:
E蛋白(E2A/HEB)调控树突状细胞(DC)分化和抗肿瘤功能机制的研究
-
批准号:32370930
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2023
-
负责人:张福萍
-
依托单位:
E2A通过Wnt/β-catenin通路对结直肠癌细胞干性的影响及其机制研究
-
批准号:81602600
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:赵红超
-
依托单位:
E蛋白(E2A/HEB)调节Treg细胞功能和稳定性的分子机制及其在炎症疾病中的意义
-
批准号:31670894
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2016
-
负责人:张福萍
-
依托单位:
新月体肾炎早期Id3通过与E2A作用调控Th17和Treg细胞分化的机制研究
-
批准号:81370817
-
项目类别:面上项目
-
资助金额:16.0万元
-
批准年份:2013
-
负责人:吕永曼
-
依托单位: